Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study's revision history now includes a new entry for v3.5.0 and removes the v3.4.3 entry. This updates the version history display without changing the underlying study data.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) removed on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedThe change is a minor site-wide version update from Revision: v3.4.1 to v3.4.2, affecting only the page footer and not study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedA new history entry Revision: v3.4.1 was added and an older government funding notice was removed; these are administrative updates that do not change trial information.SummaryDifference0.7%

- Check74 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, informing users that updates may be delayed and directing them to opm.gov for status updates.SummaryDifference0.7%

- Check82 days agoChange DetectedThe history page now shows UI enhancements such as a glossary toggle and color-coded change highlights (green for additions and red for deletions), along with updated footer notes including Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.